THE EVOLVING PHARMACOTHERAPEUTIC LANDSCAPE FOR THE TREATMENT OF SICKLE CELL DISEASE
Sickle cell disease (SCD) is an extremely heterogeneous disease that has been associated with global morbidity and early mortality. More effective and inexpensive therapiesare needed. During the last five years the landscape of the pharmacotherapy of SCD has changed dramatically. Currently, there ar...
Saved in:
| Main Author: | Samir Ballas |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PAGEPress Publications
2020-01-01
|
| Series: | Mediterranean Journal of Hematology and Infectious Diseases |
| Online Access: | http://mjhid.org/index.php/mjhid/article/view/4115 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New pharmacotherapeutic approaches for the treatment of peripheral T-cell lymphoma
by: M. А. Sorokina, et al.
Published: (2023-07-01) -
PHARMACOTHERAPEUTIC EFFICACY OF THE PREPARATION «BALIZ-2» IN TREATMENT OF INFLAMMATORY DISEASES
by: T. B. Tsydenova, et al.
Published: (2012-11-01) -
Pharmacotherapeutic perspectives on nutraceuticals in the treatment of MASLD and MASH
by: Ali H. Eid, et al.
Published: (2025-05-01) -
The Evolving Treatment Landscape of AML
by: Sabine Blum, et al.
Published: (2022-03-01) -
Gastro-oesophageal reflux: an overview of the pharmacotherapeutic treatment options
by: L Malan, et al.
Published: (2017-07-01)